Kither Biotech Doses First Patients in KIT2014 COPD Trial
TURIN, Italy — September 29, 2026 Kither Biotech Pty Ltd and Kither Biotech Srl announced that the first patients...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
TURIN, Italy — September 29, 2026 Kither Biotech Pty Ltd and Kither Biotech Srl announced that the first patients...
SAN DIEGO — September 29, 2026 Caspian Therapeutics and Kura Oncology announced new preclinical data for KO-7246, an investigational,...
Shanghai, China, September 24, 2026 Henlius has announced a strategic partnership with Amberstone Biosciences to discover and develop next-generation...
MENLO PARK, Calif. — September 28, 2026 AN2 Therapeutics, Inc. announced that the Gates Foundation has extended funding supporting...
Beijing, China, September 24, 2026 InnoCare Pharma has entered into a strategic research collaboration and license agreement with Eli...
BASEL, Switzerland — September 17, 2026 Roche announced the grand opening of the Roche Genentech Innovation Center Boston, expanding...
SOUTH SAN FRANCISCO, Calif. — September 17, 2026 Dualitas Therapeutics announced a research collaboration and license agreement with Roche...
SEATTLE, Wash. — September 15, 2026 Curi Bio announced that the U.S. Food and Drug Administration’s Center for Drug...
SOUTH SAN FRANCISCO, Calif. — September 16, 2026 Twist Bioscience Corporation announced an agreement with Lilly TuneLab, the collaborative...
Seattle, Washington, U.S., September 15, 2026 HDT Bio Corp. has received an ARPA-H GIVE award to lead the development...
